Cargando…
Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis
SUMMARY: The results of this study suggest that, under the assumption of same relative risk reduction of fractures in men as for women, strontium ranelate could be considered a cost-effective strategy compared with no treatment for the treatment of osteoporotic men from a Belgian healthcare payer pe...
Autores principales: | Hiligsmann, M., Ben Sedrine, W., Bruyère, O., Reginster, J.-Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706715/ https://www.ncbi.nlm.nih.gov/pubmed/23371359 http://dx.doi.org/10.1007/s00198-013-2272-2 |
Ejemplares similares
-
Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis
por: Reginster, J-Y., et al.
Publicado: (2011) -
Cardiac concerns associated with strontium ranelate
por: Reginster, Jean-Yves
Publicado: (2014) -
Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover
por: Collette, J., et al.
Publicado: (2009) -
Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis
por: Meunier, P. J., et al.
Publicado: (2009) -
Strontium ranelate in postmenopausal osteoporosis treatment: a critical appraisal
por: Cesareo, Roberto, et al.
Publicado: (2010)